TAX LOSE SEASONis back! Wonder how well LMNL will fare? I suspect you are going to get downward pressue on this already battered stock. AND as Edrose continues to point out there is excessive spending on management salaries and not enough on actual biotech development. The market will quickly figure out this company deserves to be on it's already downward trajectory. By the end of the 4'th quarter I'm betting they are going to announce the small molecule (4050/fezagasprus sp??) doesn't have a future after all OR or maybe they will sell it off cheaply like everything else? BUT don't forget Thomvest has control of the patents safely tucked away in the Cayman Islands.